Tilray Just Soared 40% This Week: Is the Stock a Good Buy Now?
Published
Tilray stock soared almost 40% in a single trading session this week after the U.S. DEA disclosed plans to reschedule cannabis as a Schedule III drug.
Full ArticlePublished
Tilray stock soared almost 40% in a single trading session this week after the U.S. DEA disclosed plans to reschedule cannabis as a Schedule III drug.
Full Article